explore -WSS

explore

author：explore 2025-09-02 11:43:50 - browse：71636

The experimental Alzheimer’s drug lecanemab, hailed after it slowed patients’ cognitive decline in a clinical trial, may have contributed to the death in June of a patient in the study, STAT has learned.

One investigator on the study flagged the death, noting it came after the patient experienced bleeding in the brain, and concluded it was related to the drug, according to documents obtained by STAT. Eisai, the drugmaker behind lecanemab, disagreed, pointing to other possible factors, including a series of setbacks in preceding months — multiple falls, a heart attack, a respiratory infection, and mini-stroke-like events.

Though still under investigation, the death suggests that new medicines to treat Alzheimer’s, like medicines to treat anything else, will come with their own side effects and costs. It also raises the importance of waiting for the full lecanemab data before drawing conclusions based on the positive press release put out by Eisai and its partner Biogen last month.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Why the world’s most expensive drug might be worth the price

explore

WSS

Pentagon will tighten controls on classified information after Discord leak

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

Supreme Court mifepristone arguments center on docs' right to sue

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Following judge's order, DOJ releases slightly less

EU moves toward latest gene techniques in food production to counter climate change, shortages

Wikipedia

explore

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

Medical leaders decry Supreme Court decision on affirmative action

Former New York Mayor de Blasio and wife announce separation, but not divorce

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Donor acceptance rates hint at racial, gender bias in heart transplants: study

In Memoriam: Notable people who died in 2023

States should stop sabotaging methadone treatment reform

Cancer drug shortages should be causing more outrage

The leaders of Italy and Poland say European Union should focus on stopping migration

knowledge

Study says nonprofit hospitals fall short in charity care spending

Ph.D. graduate surprised with gift registry: 'You deserve to be celebrated'

Roche subsidiary Foundation Medicine opens new headquarters

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Man pleads guilty to raping Ohio girl who ended up traveling across state lines for abortion

Roche subsidiary Foundation Medicine opens new headquarters

explore

focus

explore

hotspot